Press Releases

-- Experience Senhance Surgery at TransEnterix Booth #577 -- RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Oct. 16, 2018-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today

Receives FDA 510(k) clearance for 3mm instrument set as well as additional 5mm instruments, advancing minimally invasive capabilities within digital laparoscopy RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Oct. 11, 2018-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is

Announces four Senhance system sales in third quarter of 2018 Preliminary unaudited revenue of approximately $5.4 million for the third quarter of 2018 Preliminary unaudited cash and cash equivalents of approximately $82 million as of September 30, 2018 Announced entry into acquisition agreement

Receives CE Mark for Senhance™ Ultrasonic, Advanced Energy Capability Broadens the Potential Applicability of Senhance Surgery in CE Mark Countries RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Oct. 1, 2018-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the

Adds advanced surgical image analytics technology capabilities to Senhance digital laparoscopy platform Establishes Israel-based R&D Center RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Sep. 23, 2018-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Sep. 20, 2018-- TransEnterix, Inc. (NYSE American:TRXC) announced today that TransEnterix will participate in two upcoming healthcare conferences: Todd M. Pope , President and Chief Executive Officer will present at the 2018 Cantor Global Healthcare

Filed 510(k) submission for Senhance Ultrasonic, broadening the potential applicability of Senhance surgery in the U.S. RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Sep. 6, 2018-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Sep. 4, 2018-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Eric Smith has been named Chief

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Aug. 22, 2018-- TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at the 13th Annual Wells

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Aug. 7, 2018-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the